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Objectives. We compared the ability of rest single-photon
emission computed tomography (SPECT) with [123I]-16-iodo-3-
methylhexadecanoic acid (MIHA) and the thallium-201 (Tl-201)
rest-reinjection technique to detect myocardial viability after
infarction.
Background. After myocardial infarction, MIHA frequently
shows increased uptake in the areas with exercise Tl-201 defects
(mismatch), even in patients with an irreversible Tl-201 reinjec-
tion defect. Whether such increased uptake is indicative of
ischemic but viable myocardium is not known.
Methods. We studied 38 patients who 1) underwent exercise
SPECT Tl-201 with rest-reinjection and rest SPECT with MIHA
before undergoing percutaneous transluminal coronary angio-
plasty (PTCA) of an infarct-related coronary artery, and 2) were
found to have successful revascularization at follow-up angiogra-
phy. The relation between SPECT results before PTCA and
subsequent improvement in left ventricular wall motion was
assessed.
Results. A mismatch was evident before PTCA in 51 of 76
infarct-related segments and correlated with subsequent improve-
ment in wall motion (overall accuracy 71%), even for the 27
segments whose exercise defects remained irreversible after Tl-
201 reinjection (overall accuracy 81%). The finding of a mismatch
clearly enhanced the results provided by the finding of >250%
Tl-201 uptake as determined at redistribution (p < 0.05), but not
as determined at reinjection, although there was a trend toward a
better specificity for the findings of a mismatch.
Conclusions. MIHA is an efficient marker of viability inside
exercise-underperfused areas after infarction, even in patients
with irreversible Tl-201 reinjection defects. Assessment by con-
ventional SPECT of a mismatch between results obtained with a
metabolic tracer (MIHA) and a flow tracer analyzed at exercise
(Tl-201) as a marker of myocardial viability is a promising area of
research.
(J Am Coll Cardiol 1997;30:1241–8)
©1997 by the American College of Cardiology
In patients with coronary artery disease, left ventricular (LV)
function is one of the main determinants of long-term out-
come. In underperfused areas supplied by an infarct-related
vessel, impaired systolic function may be caused by either
irreversible myocardial damage or by ischemic but viable
(“hibernating”) myocardium (1). In the latter case, myocardial
revascularization is likely to result in improved LV function. In
this context, the noninvasive detection of ischemic but viable
myocardium after myocardial infarction (MI) represents an
important clinical goal.
Thallium-201 (Tl-201) single-photon emission computed
tomography (SPECT), particularly when using the rest-
reinjection technique, can detect the presence of viable myo-
cardium (2–7). However, it was shown that residual viability
was better detected with the use of metabolic tracers, such as
fluorodeoxyglucose, than with the Tl-201 reinjection technique
(8), even when a quantitative Tl-201 uptake analysis was
performed (9). Therefore, the development of metabolic trac-
ers that could be easily used with the SPECT technique might
be clinically useful to enhance the detection of residual viabil-
ity after acute MI.
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Labeled free fatty acids have properties that make them
particularly suitable for assessing myocardial viability (10–27):
Their myocardial uptake requires preserved oxidative metab-
olism (10), which might make them very specific markers of
viable myocardium (10–14). In addition, in viable but under-
perfused areas, certain free fatty acids have a slower clearance
rate or a higher serum extraction rate, or both (15–22), that,
through an increase in their myocardial concentration, might
facilitate their external detection by the gamma camera. [123I]-
16-iodo-3-methylhexadecanoic acid (MIHA) is a labeled free
fatty acid with a beta-methyl group that prevents its beta-
oxidation (23), so that its myocardial clearance rate is suffi-
ciently slow to allow scintitomographic acquisitions in humans
(24).
In patients with previous MI, a high level of MIHA uptake
is frequently observed within the exercise Tl-201 defect areas,
even for defects remaining irreversible after Tl-201 rest-
reinjection (25). The aim of the present study was to deter-
mine, in patients with MI and subsequently successful percu-
taneous revascularization of the infarct-related artery, whether
MIHA SPECT might provide better detection of residual
viability, defined by the presence of improved regional wall
motion at follow-up, than the Tl-201 rest-reinjection tech-
nique.
Methods
Patients. We prospectively included in our study all pa-
tients who 1) underwent both coronary angiography with LV
angiography and exercise Tl-201 SPECT with rest-reinjection
and rest MIHA SPECT at our institution after an initial
episode of MI, and 2) later had a percutaneous transluminal
coronary angioplasty (PTCA) procedure on the infarct-related
artery and were found to have successful revascularization at
follow-up angiography. We excluded patients with three-vessel
disease and patients with two-vessel disease involving both the
left circumflex and right coronary arteries. The mean time (6
SD) from radionuclide exercise studies to PTCA was 7 6 4
days (range 1 to 15). At $4 months after the revascularization
procedure, patients underwent repeat LV and coronary an-
giography. All patients gave written informed consent to
participate in the study; the radionuclide protocol was ap-
proved by the ethics committee of our institution.
Of 103 consecutive patients with MI and a subsequent
complete radionuclide study including MIHA SPECT, 75 were
subsequently referred for PTCA for a .50% diameter stenosis
on the infarct-related artery. PTCA was unsuccessful in 5 of
the 75 patients and 32 of the other 70 patients were excluded:
3 because the MIHA SPECT study could not be analyzed, 4
because they refused $4-month control angiography and 25
because $4-month control angiography showed an unsuccess-
ful revascularization result; thus, 38 patients were included in
the present analysis.
The study group comprised 29 men and 9 women with a
mean age of 59 6 9 years (range 37 to 74). Thirty-one had had
a Q wave MI and 7 (18%) a non Q wave infarct documented
by the association of prolonged chest pain and rise in cardiac
enzyme levels (.2 times the upper limit of normal). The
precise date of MI could not be determined in two patients
with ambulatory infarction; in the other 36 patients, the mean
interval between MI and the MIHA SPECT study was 32 6 39
days (range 10 days to 6 months; median 24 days). Twenty-one
patients (55%) had received intravenous thrombolytic therapy
in the acute stage of MI and two had residual angina. The
infarct-related artery was the left anterior descending coronary
artery in 22 patients (58%), a dominant right coronary artery in
10 (26%) and the left circumflex coronary artery in 6 (16%).
Thirty-two patients (84%) had single-vessel disease and six had
two-vessel disease. LV ejection fraction, calculated by the
area-length method on the 30° right anterior oblique projec-
tion, had a mean value of 51 6 11% (range 28% to 74%) and
was severely depressed (,40%) in seven patients (18% of the
overall study group). The average interval between PTCA and
follow-up angiography was 6 6 2 months.
Angiographic analyses. Coronary angiograms were ana-
lyzed without knowledge of the results of radionuclide studies
by an experienced observer using the MacIntosh-based Car-
diovascular Angiography Analysis System (CAAS II, Pie Med-
ical, Maastricht, The Netherlands). Assessment was made
from the views best showing the dilated area at end-diastole
and by specifically avoiding superimposition of side branches.
The system has been extensively validated and described in
detail elsewhere (28). The target arterial segment is video-
digitized and its contours are detected automatically. Percent
diameter stenosis is calculated by the equation: (Interpolated
reference diameter 2 Minimal lumen diameter/Interpolated
reference diameter) 3 100%.
Initial PTCA success was defined by the presence of a
residual stenosis ,50% at the dilated site with no in-hospital
complications. On follow-up angiography, successful revascu-
larization was defined by 1) residual diameter reduction #70%
at the dilated site for vessels totally occluded before PTCA and
residual diameter reduction #50% for other vessels; and 2)
absence of development of a new stenosis (.50% diameter
reduction) located elsewhere on the previously dilated artery.
LV angiograms were performed in the 30° right anterior
oblique view with the use of nonionic contrast medium (io-
hexol). To eliminate interobserver variability, a single observer
(N.D.), who was unaware of the radionuclide data, drew the
end-diastolic and end-systolic contours on paper and these
contour data were subsequently digitized.
Regional wall motion was analyzed by using the Stanford
Abbreviations and Acronyms
LV 5 left ventricle, left ventricular
MI 5 myocardial infarction
MIHA 5 [123I]-16-iodo-3-methylhexadecanoic acid
PTCA 5 percutaneous transluminal coronary angioplasty
SPECT 5 single-photon emission computed tomography
Tl-201 5 thallium-201
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method (29) with the determination of 20 radii converging on
a point located at 69% of the distance along a line drawn from
the anterolateral aortic valve edge to the most distant point of
the apex on the end-systolic frame. Four segments were
defined on the LV angiogram (Fig. 1). A mean fractional
shortening index was calculated by averaging the values of all
radii of the corresponding segment (30). The values were
normalized on those obtained in a series of 28 patients with
atypical chest pain and normal coronary and ventricular angio-
grams. Improvement in regional wall motion from before
PTCA to follow-up angiography was defined as an increase in
mean fractional shortening .10% of mean normal values. This
threshold value was found to correspond to the mean value 1
1.5 SD of the intraobserver variability in the determination of
the normalized mean fractional shortening index. This intraob-
server variability was determined by redrawing LV contours
and recalculating normalized mean fractional shortening of
segments on 20 LV angiograms analyzed at least 2 months
apart from one other.
Exercise test protocol and radionuclide studies. The exer-
cise tests were performed on a bicycle ergometer with the
patient in the upright position. The protocol began at 40 W and
increased by 30-W increments every 3 min. Exercise end points
were physical exhaustion, development of angina pectoris,
.2-mm ST segment depression, sustained ventricular tachyar-
rhythmia, exertional hypotension, or achievement of maximal
predicted heart rate. In two patients with a low physical
capacity (one with peripheral artery disease and one with a
history of stroke), dipyridamole (0.56 mg/kg body weight) was
given intravenously during a 4-min period preceding the
exercise test.
One minute before the termination of exercise, Tl-201 (37
MBq/25 kg body weight, without exceeding 111 MBq) was
injected intravenously. Stress imaging was initiated 10 to
15 min later; redistribution studies were made 3 to 5 h later
and were followed by rest-reinjection imaging, 10 min after
injection of a second dose of Tl-201 (37 MBq).
MIHA rest SPECT was performed on the same day and
immediately after Tl-201 acquisitions in 27 patients, the day
after in 9 and, in 2 patients 5 and 7 days, respectively, after the
initial Tl-201 imaging. MIHA was provided by CIS Bio Inter-
national (Gif-sur-Yvette, France). To block thyroid 123I up-
take, potassium perchlorate (200 mg) was given orally 3 to 5 h
before MIHA injection and 12, 24 and 36 h later. MIHA (110
to 200 MBq) was injected intravenously at rest, and SPECT
acquisition was initiated 15 min later.
Tomographic Tl-201 and MIHA acquisitions were per-
formed by using a rotating gamma camera equipped with a low
energy, high resolution, parallel hole collimator interfaced with
a computer system (Sopha Medical Systems, Inc.). The tech-
nique for acquisition and reconstruction of Tl-201 and MIHA
SPECT data has been described elsewhere (25).
The results were merged into four large segments (Fig. 1),
equivalent to those determined on X-ray angiograms. Only
those segments located in PTCA areas were analyzed. These
were the anterobasal and anteroapical segments for PTCA
performed on the left anterior descending artery and the
inferobasal and inferoapical segments for PTCA performed on
the left circumflex or right coronary artery.
Tl-201 image analysis. Analysis of the reconstructed tomog-
raphy Tl-201 slices was performed visually by consensus of two
experienced observers who had no knowledge of clinical and
angiographic data or the results and images from MIHA
acquisitions. Myocardial uptake was scored on a 20-area
division of the LV (Fig. 1) by using a 4-point grading system:
0 5 normal uptake, 1 5 equivocal, 2 5 moderate decrease, and
3 5 severe decrease in uptake (25). For each PTCA-related
segment, exercise Tl-201 SPECT defect reversibility was de-
Figure 1. Four-segment division of the LV applied to
both SPECT and X-ray ventriculography. vent. 5 ven-
tricular.
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fined by the presence, in at least one area, of both 1) an
exercise Tl-201 SPECT defect (uptake score $2), and 2)
increased Tl-201 uptake ($1-point decrease in uptake score)
at redistribution or reinjection (2,9,25).
The technique for the quantitative circumferential profile
analysis has been described elsewhere (25). Tl-201 uptake was
calculated, on both redistribution and reinjection scans and in
each of the PTCA-related segments, by averaging uptake
values of the segment’s radii localized in exercise underper-
fused areas (quantification restricted to radii having an exer-
cise Tl-201 uptake ,90% of mean normal values).
For the prediction of improved segmental contractility after
PTCA, three Tl-201 criteria were analyzed: 1) reversibility of
an exercise defect on Tl-201 redistribution or reinjection scans
(2,8,9), 2) $50% Tl-201 uptake at redistribution, and 3) $50%
Tl-201 uptake at reinjection (3–7,9,31–36).
MIHA image analysis. Reconstructed tomographic MIHA
slices were scored visually, 1 month after the scoring of Tl-201
scans and with the same technique (20 LV area division,
4-point grading system). The two observers had no knowledge
of the results and images from Tl-201 redistribution and
reinjection or clinical and angiographic data. For the predic-
tion of improved segmental contractility, the analyzed criterion
was the presence of a mismatch, defined by the presence, in at
least one area, of both 1) an exercise Tl-201 SPECT defect
(uptake score $2), and 2) increased uptake ($1-point de-
crease in uptake score) on MIHA scans.
Statistical analysis. The following definitions were used:
Sensitivity (%) 5 100 3 (True positives)/(True positives 1
False negatives); Specificity (%) 5 100 3 (True negatives)/
(True negatives 1 False positives); Positive predictive value
(%) 5 100 3 (True positives)/(True positives 1 False posi-
tives); Negative predictive value (%) 5 (True negatives)/(True
negatives 1 False negatives); and Overall predictive accuracy
(%) 5 100 3 (True positives 1 True negatives)/(Total number
of tests).
To determine whether the different segments from the
same patient behaved independently, an analysis of variance
was performed on the overall segments with two grouping
factors: patient number and segment number, the dependent
variable being the variation in contractility (difference in
normalized fractional shortening) between pre-PTCA and
follow-up angiograms.
Concordance between pre-PTCA SPECT results and post-
PTCA improvements in wall motion was assessed by using the
kappa statistic and expressed as kappa score 6 SD (kappa 6
SD). The concordance was considered to be good for kappa
.0.6, moderate for kappa ranging from 0.6 and 0.4, and poor
for kappa ,0.4. Enhanced prediction related to MIHA versus
Tl-201 variables was assessed by comparing the corresponding
kappa scores, assuming that distribution of (kappa1 2 kappa2)/
(SD1zkappa1 1 SD1zkappa2)
0.5 was normal under the null
hypothesis: kappa1 5 kappa2, SD1 and SD2 being the corre-
sponding standard deviations of the compared kappa values,
kappa1 and kappa2.
Comparisons between discrete variables and comparisons
between proportions were made by using the Fisher exact tests.
Continuous variables were expressed as mean value 6 SD, and
an adjusted four-group comparison was performed by using a
Kruskal-Wallis test. For all tests, a p value , 0.05 was
considered indicative of a significant difference.
Results
Exercise tests and SPECT studies before PTCA. For the
baseline exercise tests, all antianginal medications had been
discontinued in 30 (79%) of the 38 patients, and the tests were
performed without beta-blocker treatment in 36 (95%);
exercise-induced angina developed in 6 patients (16%), and 12
(32%) had exercise-induced $1-mm ST segment depression.
An exercise defect was seen on exercise Tl-201 SPECT in 70
(92%) of the 76 segments corresponding to the dilated infarct-
related arteries. Exercise defect reversibility was observed on
either Tl-201 redistribution or reinjection scans in 43 segments
(57%), and a mismatch was observed in 51 segments (67%).
A mismatch was seen in 12 segments that had no detectable
reversibility after Tl-201 reinjection; the converse (reversibility
after Tl-201 reinjection but no mismatch) was observed in 4
segments. Among the 12 segments that had a mismatch and
no reversibility after Tl-201 reinjection, 7 (58%) had $50%
Tl-201 uptake at redistribution and 11 (91%) had $50%
Tl-201 uptake at reinjection.
Viability was identified by a mismatch but totally missed by
Tl-201 redistribution or reinjection in four patients when the
criterion of exercise defect reversibility was used alone in the
Tl-201 analysis, but in none of the patients when the criterion
of $50% Tl-201 uptake at reinjection was added.
Prediction of regional wall motion improvement in the
dilated artery territory. The segments’ contractility (normal-
ized fractional shortening) had a variation after PTCA that was
not significantly related to 1) segment location in the LV area
(segment number) or 2) the patient the segments belonged to
(patient number). Among the 76 PTCA-related segments,
there was a strong relation between the presence of exercise
defect reversibility after Tl-201 reinjection or of a mismatch
and the further evolution of wall motion at follow-up. The
difference in normalized fractional shortening between
follow-up and pre-PTCA measurements was 26 6 21% in the
21 segments with two negative test results (neither mismatch
nor Tl-201 reinjection reversibility); this difference was much
greater in the 39 segments with two positive test results (122 6
25%, p , 0.001), as well as in the 4 segments having only a
Tl-201 reinjection reversibility (132 6 9%, p 5 0.01) and the
12 segments having only a mismatch (124 6 20%, p 5 0.004).
Forty-three segments (57%) showed improved wall motion
between follow-up and baseline angiography. This improve-
ment was documented for both of the two infarct-related
segments in 14 patients (37%), for only one segment in 15
patients (39%).
The predictive values of the different SPECT variables,
with regard to subsequent improvement in wall motion, are
displayed in Tables 1 and 2 and Figure 2. Improved wall
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motion was observed in 31 (72%) of the 43 segments that
displayed exercise defect reversibility on Tl-201 redistribution
or reinjection pre-PTCA scans, and in 12 (36%) of the 33
segments without exercise defect reversibility on pre-PTCA
Tl-201 scans (kappa 0.36 6 0.11). Of the 51 segments exhibit-
ing a mismatch before PTCA, 36 (71%) had subsequent
improvement in wall motion; in the 25 segments without a
mismatch, 7 (28%) had improved wall motion at follow-up
(kappa 0.39 6 0.10).
Compared with the analysis of only Tl-201 redistribution or
reinjection acquisitions, the additional analysis of the mis-
match led to a significant increase in sensitivity for the
prediction of improved wall motion (93% vs. 72%, p 5 0.01);
it also led to an enhanced global predictive value, although the
difference in kappa scores was of borderline significance
(0.50 6 0.10 vs. 0.36 6 0.11, p 5 0.07) (Table 1).
Among the 27 segments that had irreversible exercise
defects on both Tl-201 redistribution and reinjection, 11 (41%)
had improved wall motion at follow-up. The results concerning
the predictive value of MIHA analysis in this subset of
segments with irreversible defects after Tl-201 reinjection, are
displayed in Table 2 and Figure 2. Of the 12 segments having
a mismatch, 9 (75%) had subsequent improvement in regional
wall motion, whereas only 2 segments (13%) without a mis-
match had improved wall motion at follow-up (kappa 0.62 6
0.15) (Fig. 3).
Considering quantitative Tl-201 SPECT variables, the cri-
terion of a mismatch was markedly superior to that of a $50%
Tl-201 uptake on redistribution scans. This difference was
observed when considering all analyzed segments (Table 1)
and when considering only the segments with irreversible
defects on Tl-201 redistribution or reinjection scans (Table 2).
By contrast, there was no significant difference in the global
predictive value between MIHA and the $50% level of Tl-201
uptake determined at reinjection, although there was a trend
toward enhanced specificity for MIHA (all segments 55% vs.
45%; segments with irreversible Tl-201 reinjection defects 81%
vs. 75%; p 5 NS for both) (Tables 1 and 2).
Discussion
In the clinical setting, the definition of residual myocardial
viability after MI remains a matter of debate. In this regard,
improvement in regional wall motion after successful revascu-












Exercise defect reversibility on
Tl-201 redistribution 47% (20/43)*† 67% (22/33) 65% (20/31) 49% (22/45)† 58% (42/76)*† 0.12 6 0.11*†
Tl-201 redistribution on
reinjection
72% (31/43)† 64% (21/33) 72% (31/43) 64% (21/33) 68% (52/76) 0.36 6 0.11
Mismatch 84% (36/43) 55% (18/33) 71% (36/51) 72% (18/25) 71% (54/76) 0.39 6 0.10
Mismatch or reversibility on
Tl-201 redistribution or
reinjection
93% (40/43) 55% (18/33) 73% (40/55) 86% (18/21) 76% (58/76) 0.50 6 0.10
Quantitative analysis
$50% Tl-201 uptake on
Tl-201 redistribution 77% (33/43)† 45% (15/33) 65% (33/51) 60% (15/25) 63% (48/76) 0.23 6 0.11*†
Tl-201 reinjection 91% (39/43) 45% (15/33) 68% (39/57) 79% (15/19) 71% (54/76) 0.38 6 0.10
Tl-201 redistribution or
reinjection
91% (39/43) 36% (12/33) 65% (39/60) 75% (12/16) 67% (51/76) 0.29 6 0.10†
*p , 0.05 compared with mismatch. †p , 0.05 compared with mismatch or reversibility on Tl-201 redistribution or reinjection. PTCA 5 percutaneous transluminal
coronary angioplasty; SPECT 5 single-photon emission computed tomography; Tl-201 5 thallium-201.
Table 2. Predictive Values of Baseline SPECT Variables With Regard to Improved Wall Motion at Follow-Up (subset of 27 PTCA-related










Mismatch 82% (9/11) 81% (13/16) 75% (9/12) 87% (13/15) 81% (22/27) 0.62 6 0.15
$50% of Tl-201 uptake on
Tl-201 redistribution 45% (5/11) 62% (10/16) 45% (5/11) 62% (10/16) 55% (15/27)* 0.08 6 0.19*
Tl-201 reinjection 91% (10/11) 75% (12/16) 71% (10/14) 92% (12/13) 81% (22/27) 0.63 6 0.15
Tl-201 redistribution or
reinjection
91% (10/11) 56% (9/16) 59% (10/17) 90% (9/10) 70% (19/27) 0.43 6 0.15
*p , 0.05 compared with mismatch. Abbreviations as in Table 1.
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larization of the underperfused myocardium probably consti-
tutes the best clinically relevant definition of residual myocar-
dial viability, and we therefore used it as the end point in the
present study.
In clinical practice, Tl-201 SPECT has become one of the
most commonly used techniques for assessing residual myo-
cardial viability, and the rest-reinjection technique has mark-
edly enhanced its diagnostic ability in this setting (2–7).
However, certain clinical reports have suggested that the
Tl-201 rest-reinjection technique provides an imperfect esti-
mation of the amount of residual viability (8), even when a
quantitative Tl-201 uptake analysis is performed (9, 34–36).
In the areas with exercise Tl-201 SPECT defects in patients
with MI, rest SPECT with MIHA yielded higher rates of
increased uptake than the Tl-201 rest-reinjection technique
(25). This mismatch between a flow (Tl-201) and a metabolic
Figure 2. Changes in wall motion at follow-up, as a
function of the presence on pre-PTCA scans of an exercise
defect with reversibility at Tl-201 reinjection or of a
mismatch, or of both.
Figure 3. SPECT acquisitions (left) and X-ray
angiograms in the 30° right anterior oblique
view (right) in a 70-year old man who had a Q
wave nonthrombolyzed MI, an 82% diameter
stenosis of the left anterior descending coro-
nary artery (LAD) and irreversible exercise
Tl-201 SPECT defects after Tl-201 rest-
reinjection at baseline. A large mismatch at
baseline (septal, apical, anterior and inferior
walls) correlated with subsequent improve-
ments in exercise perfusion and wall motion on
follow-up exercise Tl-201 SPECT and X-ray
angiography performed 6 months after PTCA
of the LAD.
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(MIHA) tracer was unrelated to the difference in the normal
distribution between the two tracers and might thus corre-
spond to areas of ischemic and viable myocardium, misidenti-
fied by the analysis of defect reversibility on Tl-201 scans (25).
Viability detection by MIHA. The present study confirms
that the criterion of a mismatch is strongly related to late
improvement in wall motion after PTCA. Moreover, this
relation remains particularly significant for segments with
irreversible exercise defects after Tl-201 reinjection.
When all PTCA-related segments in our study were con-
sidered, the sensitivity of the mismatch to predict improvement
in wall motion was high; however, the specificity was lower. A
possible explanation is that the angiographic single-plane 30°
right anterior oblique view was not sufficiently sensitive to
detect enhanced contractility after PTCA. In our study, how-
ever, as in most studies in patients with recent MI, high rates
of anterior MI with LV aneurysms did not allow an accurate
analysis of the additional 60° left anterior oblique orientation.
Comparison with quantified Tl-201 uptake analysis. Sev-
eral studies (3–7,31–37) have demonstrated that quantification
of Tl-201 uptake might provide potent information about
viability, independent of the presence or absence of a defect
reversibility. Although several of these studies used the Tl-201
redistribution technique only, quantified Tl-201 uptake has
been shown (37) to correlate better with the amount of
myocardial fibrosis when analyzed at reinjection. In addition,
,50% Tl-201 uptake at reinjection has been considered to
reflect lack of residual viability (3–7), although recent reports
(9,34–36) have indicated very low specificity for this quantita-
tive Tl-201 criterion.
The design of these previous studies was quite different
from the present one. Several studies (3–7) used positron
emitting tracers to establish the presence of myocardial viabil-
ity. Furthermore, none focused specifically on patients with
recent MI. The radionuclide investigations in the present study
were performed in the first weeks after an episode of acute MI;
however, they were never performed in the 1st 10 days, during
which the uptake of fatty acids may be decreased in viable
myocardium (38,39), a phenomenon that might be related to a
glycolytic shift of the energetic metabolism in areas of stunned
myocardium (13).
In the present study, the criterion of a mismatch was
markedly superior to that of a $50% level of Tl-201 uptake,
when determined on redistribution scans, but we failed to
demonstrate a significant difference in global accuracy from
the $50% level of Tl-201 uptake determined after reinjection.
However, our results suggest that MIHA may be more specific
than Tl-201 quantification at reinjection. Further studies,
performed in a much larger patient group, are needed to assess
this hypothesis. In addition, the two techniques should be more
extensively compared in patients having severe LV dysfunc-
tion.
Conclusions. The present study gives evidence that MIHA
is an efficient marker of viability within the exercise underper-
fused areas of patients with recent MI, even in patients with
irreversible Tl-201 reinjection defects. Our results also show
that viability may be accurately assessed by using conventional
SPECT and by looking for a mismatch pattern between a
metabolic tracer (MIHA) and a flow tracer whose uptake may
be analyzed during “physiologic” stress (exercise Tl-201).
These findings suggest an original and promising area for
research in the setting of viability detection.
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